Daniela Boggiani
Impact in
-
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 4
- PARP inhibition in cancer therapy 3
- Cancer Treatment and Pharmacology 2
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Andrea Ardizzoni (4 shared papers)Antonino Musolino (13 shared papers)Beatrice Bortesi (7 shared papers)Marco Bartolotti (1 shared paper)Marcello Tiseo (2 shared papers)Gabriella Sammarelli (1 shared paper)Cecilia Bozzetti (1 shared paper)Francesco Gelsomino (1 shared paper)
In The Last Decade
Daniela Boggiani
18 papers receiving 357 citations
Peers
Comparison fields: 5 of 41
- Oncology 164
- Cancer Research 70
- Pulmonary and Respiratory Medicine 125
- Pathology and Forensic Medicine 58
- Genetics 48
Countries citing papers authored by Daniela Boggiani
This map shows the geographic impact of Daniela Boggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Boggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Boggiani more than expected).
Fields of papers citing papers by Daniela Boggiani
This network shows the impact of papers produced by Daniela Boggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Boggiani. The network helps show where Daniela Boggiani may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Boggiani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 107 | |
| 2 | 2010 | 41 | |
| 3 | 2012 | 25 | |
| 4 | 2016 | 25 | |
| 5 | 2019 | 24 | |
| 6 | 2024 | 22 | |
| 7 | 2017 | 19 | |
| 8 | 2013 | 17 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2015 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 8 | |
| 14 | Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study. | 2016 | 7 |
| 15 | 2020 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2021 | 1 | |
| 18 | 2026 | 1 | |
| 19 | 2024 | 0 |
About Daniela Boggiani
Daniela Boggiani is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 19 papers that have together received 361 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (4 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), PARP inhibition in cancer therapy (3 papers), CRISPR and Genetic Engineering (2 papers), Breast Cancer Treatment Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (164 citations), Cancer Research (70 citations), Pulmonary and Respiratory Medicine (125 citations), Pathology and Forensic Medicine (58 citations) and Genetics (48 citations). Daniela Boggiani has collaborated with scholars based in Italy, France and Spain. Frequent co-authors include Andrea Ardizzoni, Antonino Musolino, Beatrice Bortesi, Marco Bartolotti, Marcello Tiseo, Gabriella Sammarelli, Cecilia Bozzetti, Francesco Gelsomino, Maria Michiara and Benedetta Giovanna Pellegrino. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, ESMO Open, The Breast and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.